This trial will help researchers understand if a transcranial photobiomodulation (tPBM) can improve neural oscillations for people with Down syndrome.
3 Primary · 0 Secondary · Reporting Duration: Baseline to Post-Treatment (~6 weeks)
Experimental Treatment
Non-Treatment Group
23 Total Participants · 2 Treatment Groups
Primary Treatment: Near-Infrared Transcranial Photobiomodulation · Has Placebo Group · N/A
Age 18 - 30 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: